# Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

> **NCT02649504** · PHASE3 · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Dexamethasone
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02649504
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12-01
- **Primary completion:** 2016-12-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649504, "Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02649504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*